BeOne Medicines (BEIGF) Cash & Equivalents Growth (3y) (2018 - 2026)
BeOne Medicines (BEIGF) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
24.73% |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
21.66% |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
- |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
10.63% |
| Date | Value |
|---|
| Mar 31, 2026 |
10.63% |
| Dec 31, 2025 |
5.53% |
| Sep 30, 2025 |
2,664.84% |
| Jun 30, 2025 |
-15.27% |
| Mar 31, 2025 |
1,868.29% |
| Dec 31, 2024 |
1,900.87% |
| Sep 30, 2024 |
25.00% |
| Jun 30, 2024 |
13.43% |
| Mar 31, 2024 |
1,992.23% |
| Dec 31, 2023 |
31.91% |
| Sep 30, 2023 |
27.95% |
| Jun 30, 2023 |
2,192.65% |
| Mar 31, 2023 |
2,223.78% |
| Dec 31, 2022 |
84.31% |
| Sep 30, 2022 |
-76.26% |
| Jun 30, 2022 |
577.56% |
| Mar 31, 2022 |
-71.92% |
| Dec 31, 2021 |
-71.75% |
| Sep 30, 2021 |
356.30% |
| Jun 30, 2021 |
59.42% |
